{"id":964,"date":"2021-11-11T12:25:00","date_gmt":"2021-11-11T12:25:00","guid":{"rendered":"https:\/\/quantadt.wpengine.com\/us\/?p=964"},"modified":"2023-09-21T16:15:50","modified_gmt":"2023-09-21T16:15:50","slug":"quanta-to-participate-in-upcoming-virtual-investor-conferences","status":"publish","type":"post","link":"https:\/\/quantadt.com\/us\/quanta-to-participate-in-upcoming-virtual-investor-conferences\/","title":{"rendered":"Quanta to Participate in Upcoming Virtual Investor Conferences"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">ALCESTER, England and BEVERLY, Massachusetts, 9 November 2021: Quanta Dialysis Technologies Ltd (\u201cQuanta\u201d or the \u201cCompany\u201d), a medical technology leader delivering on its vision for more flexible and accessible dialysis care, announced today John E. Milad, Chief Executive Officer, will be participating in three upcoming investor conferences.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Jefferies London Healthcare Conference<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Management will participate in investor 1&#215;1 meetings on Tuesday, November 16 through Thursday, November 18.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health &amp; Services Forum<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Date: Thursday, November 18<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Time: 2:00pm GMT\/9:00am EST<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Webcast: https:\/\/wsw.com\/webcast\/canaccord61\/qdtl\/2462793<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Piper Sandler 33rd Annual Virtual Healthcare Conference<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">An on-demand, pre-recorded, presentation will be made available on the conference website starting on Monday, November 22, 2021 at 10:00 a.m. ET<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Management will be participating in 1&#215;1 meetings on Monday, November 29, meetings can be requested exclusively via Piper Sandler.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ALCESTER, England and BEVERLY, Massachusetts, 9 November 2021: Quanta Dialysis Technologies Ltd (\u201cQuanta\u201d or the \u201cCompany\u201d), a medical technology leader delivering on its vision for more flexible and accessible dialysis care, announced today John E. Milad, Chief Executive Officer, will be participating in three upcoming investor conferences. Jefferies London Healthcare Conference Management will participate in [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","footnotes":""},"categories":[7],"tags":[],"class_list":["post-964","post","type-post","status-publish","format-standard","hentry","category-articles"],"acf":[],"_links":{"self":[{"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/posts\/964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/comments?post=964"}],"version-history":[{"count":0,"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/posts\/964\/revisions"}],"wp:attachment":[{"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/media?parent=964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/categories?post=964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/quantadt.com\/us\/wp-json\/wp\/v2\/tags?post=964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}